ZC

Zach Collins

Partner at Mission BioCapital

San Francisco Bay Area

Overview

Work Experience

MB

Mission BioCapital

  • Partner

    2024 - Current

  • Principal

    2021 - 2024

  • Associate

    2019 - 2021

  • Analyst

    2018 - 2019

MB

MBC Biolabs

  • Entrepreneur Success Partner

    2020

AT

Alessa Therapeutics, Inc.

  • Chief Business Officer

    2022

NT

Nuvig Therapeutics Inc.

  • Board Observer

    2021

SB

Stealth Biotech Startup

  • Board Obsever

    2021

HM

Harvard Medical School

  • Postdoctoral Research Fellow

    2018 - 2018

  • Graduate Student Researcher

    2013 - 2018

    • Uncovered a novel genetic feedback mechanism regulating the differentiation of neural stem cells • Designed and developed CRISPR Cas9 based genome engineering techniques • Collaborated on research projects using cutting edge light-sheet microscopy and single cell genomics

Harvard Biotech Incubator

  • Team Member

    2017 - 2018

    • Performed market research for a CAR T-cell therapy being developed at the Dana-Farber Cancer Institute • Presented due-diligence and regulatory strategy findings to a team of scientists and entrepreneurs

CS

Cold Spring Harbor Laboratory

  • Undergraduate Research Program Student

    2012 - 2012

Education

Relevant Websites